Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu (Q40607649)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2001
edit
Language Label Description Also known as
English
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
scientific article published on January 2001

    Statements

    Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu (English)
    Schwaab T
    Lewis LD
    Cole BF
    Fanger MW
    Wallace P
    Guyre PM
    Kaufman PA
    Heaney JA
    Schned AR
    Harris RD
    Ernstoff MS
    1 January 2001
    79-87

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit